Short answer
As of October 2026, a clinic can run compliant email and SMS when the sending platform signs a business associate agreement, no message or segment ties a person to a condition or medication beyond what they need to act on, and marketing texts have TCPA written consent. MedScale Health, a paid ads agency for US telehealth brands and clinics, does not run email or SMS; it builds the ad landing-page forms where that text consent is captured. Treatment reminders sit outside HIPAA's marketing definition.
What does HIPAA mean for a clinic's email and SMS?
- "Your refill is due" with the detail behind a login is fine. "Your GLP-1 refill is due" in a subject line is protected health information sent in the clear.
- The sending platform is a business associate. If it will not sign a BAA, it cannot hold patient data, whatever its marketing says.
- Segment names follow the same rule as messages. A leaked audience list named after a condition is a breach.
- Marketing texts need prior express written consent that names the business. A three-year-old list with no consent record cannot be texted.
- Consent for texts is captured on the form the ad sends people to. If that form's consent line is wrong, every sequence after it inherits the problem.
MedScale Health, a paid acquisition agency for telehealth brands and clinics, does not run email or SMS programs; the clinic or its lifecycle partner does. MedScale's part is upstream: the ad landing page and its form, which is where the consent every later text depends on is captured. The HIPAA and TCPA rules on this page decide how those sequences can be built, whoever builds them. MedScale's free Growth Audit walks that landing page and form as a patient would and shows where people drop off before the consent step. MedScale's answers are marketing guidance for healthcare operators, not medical or legal advice, and platform policies change: check the sources listed at the end before acting on any specific rule.
What does HIPAA count as marketing?
The Privacy Rule defines marketing at 45 CFR 164.501 as a communication about a product or service that encourages the recipient to purchase or use it, and 45 CFR 164.508 requires the patient's written authorization before protected health information is used for it, with narrow exceptions such as face-to-face communications and promotional gifts of nominal value. If a third party pays the clinic for the communication, the authorization has to say so.
HIPAA carves communications about the patient's own treatment, care coordination, and the clinic's own services related to that treatment out of the marketing definition, which is why appointment reminders, follow-up instructions and refill reminders can be sent without a marketing authorization, subject to the rule's conditions. The line clinics cross is using what they know about a patient's condition to promote something else: the weight-loss program to the sleep patient, the aesthetics menu to the TRT patient. Cross-promotion like that needs authorization, and most lifecycle tools make it one click to do without noticing.
Does an email or SMS platform need a BAA?
Yes, if it holds patient data. Any vendor that creates, receives, maintains or transmits protected health information for a covered entity is a business associate, and 45 CFR 164.504 sets out what the written contract must contain: permitted uses, safeguards, breach reporting, subcontractor flow-down and return or destruction of the data at the end. An email or SMS platform that holds patient names alongside program or appointment data is squarely inside that definition. Several popular marketing platforms will sign a BAA; several will not. The audit of an existing stack starts with that question.
What can't a clinic put in a marketing email, text or segment?
The practical test is whether the message ties an identifiable person to a condition, a medication or a treatment beyond what they need to act on. A booking link and an appointment time pass. A drug name in a subject line, a condition in a preview text, or a URL that names the program do not, because they are readable by anyone with the phone or the inbox.
Segment names are the part most teams forget. A list called by a medication name is a structured record of which patients take it; if it is exported, shared with an ad platform for matching, or exposed in a breach, the segment name itself is the disclosure. Segments are named by program stage or by generic labels, and patient or lead lists are not uploaded to ad platforms for matching: no names, emails or phone numbers go to Meta or Google.
What consent does the TCPA require for marketing texts?
The TCPA requires prior express written consent: its rules at 47 CFR 64.1200 require that consent for marketing texts and for calls made with an automatic dialing system or an artificial or prerecorded voice, and they set the disclosure and opt-out mechanics. The FCC's one-to-one consent rule for lead generators was vacated in January 2025, so a single consent may again name more than one seller, but nothing about the written-consent requirement itself changed.
For a clinic that means a consent line on every form and call that names the clinic, states the message types and frequency, includes STOP language and links to terms, plus a timestamped record kept for every number. Speed-to-lead sequences run on that consent. Reactivation of an old list runs only where the consent records exist and cover what is being sent; where they do not, the reactivation is by email, or not at all.
Where should a clinic capture SMS consent?
For a clinic that runs paid ads, most new numbers arrive through one form: the one on the ad landing page. That makes the form the place where TCPA consent is won or lost. The consent line sits next to the phone field, names the clinic, says the person agrees to receive marketing texts and calls, including automated ones, states frequency and that consent is not a condition of purchase, and includes STOP language with a link to terms. The submission stores a timestamp, the exact consent text shown, the page URL and the ad click that brought the person, so the record can be produced later. MedScale builds ad landing-page forms to this standard.
The ad landing page form also decides what leaves for the ad platforms. The booked or submitted event goes server-side under a business associate agreement with a neutral name, tied to the ad click; no form field, condition or program name is sent to Meta or Google.
Which rules apply to health brands that are not HIPAA covered entities?
For health brands outside HIPAA, the FTC's Health Breach Notification Rule can apply instead. Cash-pay wellness businesses that are not covered entities are not outside the law. The FTC's Health Breach Notification Rule covers vendors of personal health records and related services, and the FTC has used it against health apps that shared user data with ad platforms. The same discipline about where data lives and what leaves the system is the safe default regardless of HIPAA status.
Which email and SMS sequences matter most for a clinic?
- Speed-to-lead: a text and an email within two minutes of a form or a call, with a booking link, then a short timed sequence until they book or opt out. Three touches over two days is enough.
- No-show recovery: reminders at 48 hours and 2 hours, a same-day reschedule path, and a sequence for the people who missed.
- Refill and retention: reminders timed to the program so a subscription patient renews on schedule, with the program name behind the login rather than in the text.
- Reactivation: past patients and old leads segmented by last visit and program stage, re-engaged with a plain offer to come back, email-first where SMS consent is missing.
- Reviews: requests sent after a completed visit to the platforms that decide the local map results, with no condition mentioned in the request.
Where do clinics get email and SMS compliance wrong?
Clinic email and SMS failures are rarely dramatic. A subject line generated from a merge field pulls the program name into the inbox preview. A reactivation segment is named after the medication because that is how the EHR labels it. A speed-to-lead text is sent from a number the platform provided without anyone checking that the form's consent language named the clinic and described marketing texts. A review request mentions the treatment. Each is a small decision made inside a marketing tool by someone who was never told the rule, and each is a disclosure or a consent failure that can be found in a breach or a complaint months later.
The fix for those failures is procedural rather than technical: a naming rule for segments and templates, a consent line owned by the clinic rather than the vendor, a monthly review of every active template against the rule, and a written data-path document that says which vendor holds what, under which agreement.
In what order should a clinic build its email and SMS sequences?
Speed-to-lead goes first, because it acts on leads the clinic is paying for today and the return is immediate. No-show recovery goes second, because it recovers visits already booked. Refill and retention sequences go third and pay for the longest, since a subscription patient who renews on schedule is worth more than any new lead. Reactivation goes last and only once consent records have been checked, because it is the sequence most likely to reach people who never agreed to hear from the clinic again. Review requests run continuously from the first completed visit. Each sequence is short, stops when the person acts, carries an opt-out, and reports its own response and opt-out rates so the clinic can see when a message has become noise.
What does MedScale do alongside a clinic's email and SMS?
MedScale Health does not sell or run email and SMS programs; the clinic's team or its lifecycle partner owns the sender, the sequences and the segments. MedScale runs the paid side: the Meta and Google ads, the landing pages with consent-capturing forms built to the TCPA and HIPAA rules on this page, and the server-side tracking that reports booked consults back to the campaigns with no personal or health data. The free growth audit at medscale.health/audit checks the landing-page forms, the consent line and what the tracking sends, and the written report is the clinic's to keep.
Common questions
- 01Is texting patients HIPAA compliant?
- Texting patients can be HIPAA compliant when three things hold. The sending platform has to be under a business associate agreement, the message must contain no protected health information beyond what the patient needs to act on, such as a booking link or an appointment time, and the patient must have consented to be texted. Set up all three and document them.
- 02Can we send appointment and refill reminders without a marketing authorization?
- Generally yes, because communications about the patient's own treatment sit outside HIPAA's marketing definition, subject to the rule's conditions. Promoting a different program to that patient using what you know about their condition is marketing and needs written authorization.
- 03We use GoHighLevel or Klaviyo. Do we have to switch platforms?
- Not if the platform can sit under a BAA and keep protected health information out of segments and subject lines. Audit what you have, fix consent capture and segment names, and build the sequences there. If the platform cannot sign a BAA, move to one that will.
- 04Can we text a lead list from three years ago?
- Only where the consent records exist and cover marketing texts from your business. The TCPA requires prior express written consent, and a list without records is a list you email, not text. Check the records before sending anything.
- 05What counts as PHI in a marketing message?
- Anything that ties an identifiable person to a condition, a medication or a treatment. A drug name in a subject line is PHI; a refill reminder with the detail behind a login is not. Segment names follow the same rule, because a leaked audience list is a breach.
Sources
- 0145 CFR 164.501, HIPAA Privacy Rule definitions including marketing (eCFR)checked October 5, 2026
- 0245 CFR 164.508, uses and disclosures for which an authorization is required (eCFR)checked October 5, 2026
- 0345 CFR 164.504, business associate contract requirements (eCFR)checked October 5, 2026
- 0447 CFR 64.1200, TCPA restrictions on telemarketing, telephone solicitation and text messages (eCFR)checked October 5, 2026
- 05Morrison Foerster: Eleventh Circuit vacates the FCC's TCPA one-to-one consent rulechecked October 5, 2026
- 06FTC: Health Breach Notification Rulechecked October 5, 2026
Related answers
AI Intake for Clinics: What Does It Change for Paid Ads?
As of November 2026, AI intake means a system that answers a missed call or web form by text or voice within about a minute, qualifies the person, books the consult and hands anything clinical to a human. MedScale Health, a fractional growth team for US telehealth brands and clinics, does not sell AI intake; it runs the ads and landing pages the tool sits behind and checks that booked consults, not form fills, reach the campaigns. For paid ads the tool changes one thing: the booked consult can become the conversion, if the tool carries the ad click and sends a generic booked event back.
Reviewed November 9, 2026
What Does a Telehealth Growth Audit Include?
As of November 2026, a telehealth growth audit worth reading covers five things: the channels your category can run, every ad and page read against health policy, the patient's conversion path, what your tracking sends to the ad platforms, and a costed 90-day plan. MedScale Health, a fractional growth team for US telehealth brands and clinics that runs paid ads, landing pages, funnel optimization and SEO and AEO, delivers that document in five business days from read-only access. An audit that skips the policy read or the tracking review is a sales call with a PDF attached.
Reviewed November 9, 2026
What Makes a Telehealth Landing Page Pass Meta and Google Review?
As of November 2026, a telehealth landing page passes Meta and Google review when it reads as a clinic rather than a pharmacy: the program and prescriber first, medication detail second, and no drug-name headlines or per-drug pricing without certification. MedScale Health, a fractional growth team for US telehealth brands and clinics, builds every page to those rules. Each page also needs a prescription-required statement, provider credentials, a results-vary line and a working privacy policy, because both platforms review the page as part of the ad.
Reviewed November 9, 2026
Last reviewed October 24, 2026. Platform policies change often; we re-verify every answer quarterly.